Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis

摘要

IntroductionIron administration especially intravenous iron therapy is associated with improvements in exercise capacity and quality of life in patients with chronic heart failure (CHF). Our aim was to assess effect of ferric carboxymaltose (FCM) on hospitalization and mortality outcomes in CHF.